Protein Official symbol | MIF |
Aliases | MIF GLIF MMIF |
Chromosomal Location | 10 |
Length | 115 |
Uniprot ID | P14174 |
EC number | 5.3.2.1; 5.3.3.12 |
Protein family Information(Pfam) | PF01187; |
PDB id | 1CA7;1CGQ;1GCZ;1GD0;1GIF;1LJT;1MIF;1P1G;2OOH;2OOW;2OOZ;3B9S;3CE4;3DJH;3DJI;3HOF;3IJG;3IJJ;3JSF;3JSG;3JTU;3L5P;3L5R;3L5S;3L5T;3L5U;3L5V;3SMB;3SMC;3U18;3WNR;3WNS;3WNT;4ETG;4EUI;4EVG;4F2K;4GRN;4GRO;4GRP;4GRQ;4GRR;4GRU;4GUM;4K9G;4OSF;4OYQ;4P01;4P0H;4PKK;4PKZ;4PLU;4TRF;4TRU;4WR8;4WRB;4XX7;4XX8;4Z15;4Z1T;4Z1U;5B4O;5BS9;5BSC;5BSI;5BSJ;5EIZ;5HVS;5HVT;5HVV;5J7P;5J7Q;5UMJ;5UMK;5UZY;5V70;5V73;5XEJ;6B1C;6B1K;6B2C;6BG6;6BG7;6CB5;6CBF;6CBG;6CBH;6FVE;6FVH;6PEG; |
InterPro ID | IPR001398;IPR019829;IPR014347; |
dbSNP | None |
Protein 1 | Protein 2 | Combine Score |
---|---|---|
TAT | HPD | 0.994 |
MIF | CD74 | 0.979 |
TAT | GOT2 | 0.941 |
GOT1 | GOT2 | 0.931 |
GOT1 | TAT | 0.93 |
GOT1 | HPD | 0.928 |
HPD | GOT2 | 0.927 |
GOT2 | MIF | 0.925 |
GOT1 | MIF | 0.911 |
STAT4 | MIF | 0.91 |
IL4I1 | HPD | 0.91 |
IL4I1 | MIF | 0.901 |
TAT | MIF | 0.9 |
HPD | MIF | 0.9 |
# | 6898 (TAT) | 4282 (MIF) | 2805 (GOT1) | 3242 (HPD) | 2806 (GOT2) | 6775 (STAT4) | 259307 (IL4I1) | 972 (CD74) |
---|---|---|---|---|---|---|---|---|
6898 (TAT) | 1.00 | 0.59 | 0.52 | 0.16 | 0.53 | 0.57 | 0.27 | 0.62 |
4282 (MIF) | 0.59 | 1.00 | 0.16 | 0.18 | 0.26 | 0.62 | 0.27 | 0.65 |
2805 (GOT1) | 0.52 | 0.16 | 1.00 | 0.18 | 0.71 | 0.15 | 0.32 | 0.11 |
3242 (HPD) | 0.16 | 0.18 | 0.18 | 1.00 | 0.18 | 0.14 | 0.55 | 0.14 |
2806 (GOT2) | 0.53 | 0.26 | 0.71 | 0.18 | 1.00 | 0.24 | 0.29 | 0.24 |
6775 (STAT4) | 0.57 | 0.62 | 0.15 | 0.14 | 0.24 | 1.00 | 0.23 | 0.64 |
259307 (IL4I1) | 0.27 | 0.27 | 0.32 | 0.55 | 0.29 | 0.23 | 1.00 | 0.19 |
972 (CD74) | 0.62 | 0.65 | 0.11 | 0.14 | 0.24 | 0.64 | 0.19 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MIF | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 1.4 | RT-qPCR | Western US | C57BL/6 mice | 2.6 | 7600m mice(8% oxygen with Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
MIF | Mice | Blood | 8% Oxygen | 7600 m | 24 hours | upregulated | 5.2 | RT-qPCR | Western US | C57BL/6 mice | 2.6 | 7600m mice(8% oxygen with no Fenofibrate injections Vs Baseline normoxia mice (21% oxygen) | 24183776 |
MIF | Human | Vascular Smooth Muscles | 3-10% Oxygen | 5800 m | 2 hours | upregulated | - | - | - | - | - | Soldier exposed to high altitude compared to their low altitude profile | http://dx.doi.org/10.4172/jpb.S3-004 |
TF | TF Entrez | Gene | Gene Entrez | Type | PMID | Database |
---|---|---|---|---|---|---|
EP300 | 2033 | MIF | 4282 | distal | 22955619 | TRANSFAC |
CTCF | 10664 | MIF | 4282 | proximal_filtered | 22955619 | TRANSFAC |
NFKB1 | 4790 | MIF | 4282 | Activation | 17018379 | TRUSST |
SP1 | 6667 | MIF | 4282 | Unknown | 10601358 | TRUSST |
RELA | 5970 | MIF | 4282 | Activation | 17018379 | TRUSST |
HBP1 | 26959 | MIF | 4282 | Repression | 10601358 | TRUSST |
HIF1A | 3091 | MIF | 4282 | Activation | 19717648 | TRUSST |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT000046 | hsa-miR-451a | Homo sapiens | MIF | 4282 | Homo sapiens | ELISA//Luciferase reporter assay//Microarray//qRT-PCR//Western blot | Functional MTI | 19318487 |
MIRT000046 | hsa-miR-451a | Homo sapiens | MIF | 4282 | Homo sapiens | Luciferase reporter assay//Western blot | Functional MTI | 24138931 |
MIRT000046 | hsa-miR-451a | Homo sapiens | MIF | 4282 | Homo sapiens | Luciferase reporter assay | Functional MTI | 26884830 |
MIRT000046 | hsa-miR-451a | Homo sapiens | MIF | 4282 | Homo sapiens | Luciferase reporter assay | Functional MTI | 28086136 |
MIRT037678 | hsa-miR-744-5p | Homo sapiens | MIF | 4282 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT039145 | hsa-miR-769-5p | Homo sapiens | MIF | 4282 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT044670 | hsa-miR-320a | Homo sapiens | MIF | 4282 | Homo sapiens | CLASH | Functional MTI (Weak) | 23622248 |
MIRT733415 | hsa-miR-146a-5p | Homo sapiens | MIF | 4282 | Homo sapiens | Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 27569893 |
MIRT734321 | hsa-miR-1228-5p | Homo sapiens | MIF | 4282 | Homo sapiens | ELISA//Luciferase reporter assay//qRT-PCR//Western blot | Functional MTI | 28465246 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
4282 | GO:0006954 | inflammatory response | GOTERM_BP_DIRECT |
4282 | GO:0010629 | negative regulation of gene expression | GOTERM_BP_DIRECT |
4282 | GO:0001516 | prostaglandin biosynthetic process | GOTERM_BP_DIRECT |
4282 | GO:0007569 | cell aging | GOTERM_BP_DIRECT |
4282 | GO:0007166 | cell surface receptor signaling pathway | GOTERM_BP_DIRECT |
4282 | GO:0002906 | negative regulation of mature B cell apoptotic process | GOTERM_BP_DIRECT |
4282 | GO:0008283 | cell proliferation | GOTERM_BP_DIRECT |
4282 | GO:0061078 | positive regulation of prostaglandin secretion involved in immune response | GOTERM_BP_DIRECT |
4282 | GO:0005515 | protein binding | GOTERM_MF_DIRECT |
4282 | GO:0050178 | L-xylulose reductase | GOTERM_MF_DIRECT |
4282 | GO:0043066 | negative regulation of apoptotic process | GOTERM_BP_DIRECT |
4282 | GO:0090344 | negative regulation of cell aging | GOTERM_BP_DIRECT |
4282 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response | GOTERM_BP_DIRECT |
4282 | GO:0005576 | extracellular region | GOTERM_CC_DIRECT |
4282 | GO:2000343 | positive regulation of chemokine | GOTERM_BP_DIRECT |
4282 | GO:0005125 | cytokine activity | GOTERM_MF_DIRECT |
4282 | GO:0005126 | cytokine activity | GOTERM_MF_DIRECT |
4282 | GO:0042056 | neurexin family protein binding | GOTERM_MF_DIRECT |
4282 | GO:0030330 | DNA damage response | GOTERM_BP_DIRECT |
4282 | GO:0043518 | negative regulation of DNA damage response | GOTERM_BP_DIRECT |
4282 | GO:0070207 | protein homotrimerization | GOTERM_BP_DIRECT |
4282 | GO:0005102 | receptor binding | GOTERM_MF_DIRECT |
4282 | GO:0050715 | positive regulation of cytokine secretion | GOTERM_BP_DIRECT |
4282 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway | GOTERM_BP_DIRECT |
4282 | GO:0048146 | positive regulation of fibroblast proliferation | GOTERM_BP_DIRECT |
4282 | GO:0042327 | positive regulation of phosphorylation | GOTERM_BP_DIRECT |
4282 | GO:0043406 | positive regulation of MAP kinase activity | GOTERM_BP_DIRECT |
4282 | GO:0004167 | dihydroorotase activity | GOTERM_MF_DIRECT |
4282 | GO:0010739 | positive regulation of protein kinase A signaling | GOTERM_BP_DIRECT |
4282 | GO:0032269 | negative regulation of cellular protein metabolic process | GOTERM_BP_DIRECT |
4282 | GO:0045087 | innate immune response | GOTERM_BP_DIRECT |
4282 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | GOTERM_BP_DIRECT |
4282 | GO:0009986 | cell surface | GOTERM_CC_DIRECT |
4282 | GO:0030890 | positive regulation of B cell proliferation | GOTERM_BP_DIRECT |
4282 | GO:0005654 | nucleoplasm | GOTERM_CC_DIRECT |
4282 | GO:0019752 | carboxylic acid metabolic process | GOTERM_BP_DIRECT |
4282 | GO:0050900 | leukocyte migration | GOTERM_BP_DIRECT |
4282 | GO:0005615 | extracellular space | GOTERM_CC_DIRECT |
4282 | GO:0005737 | cytoplasm | GOTERM_CC_DIRECT |
4282 | GO:0043030 | regulation of macrophage activation | GOTERM_BP_DIRECT |
4282 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | GOTERM_BP_DIRECT |
4282 | GO:0031982 | vesicle | GOTERM_CC_DIRECT |
4282 | GO:0033033 | negative regulation of myeloid cell apoptotic process | GOTERM_BP_DIRECT |
4282 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | GOTERM_BP_DIRECT |
4282 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | GOTERM_BP_DIRECT |
4282 | GO:0050918 | positive chemotaxis | GOTERM_BP_DIRECT |
4282 | GO:0071157 | negative regulation of cell cycle arrest | GOTERM_BP_DIRECT |
4282 | GO:0090238 | positive regulation of arachidonic acid secretion | GOTERM_BP_DIRECT |
4282 | GO:0043209 | myelin sheath | GOTERM_CC_DIRECT |
4282 | GO:0070062 | extracellular exosome | GOTERM_CC_DIRECT |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
MIF | 4282 | Colitis | C0009319 | Disease or Syndrome | 0.51 | 0.457 | 0.862 | disease |
MIF | 4282 | Keloid | C0022548 | Acquired Abnormality | 0.3 | 0.457 | 0.862 | phenotype |
MIF | 4282 | Pyemia | C0034189 | Pathologic Function | 0.3 | 0.457 | 0.862 | phenotype |
MIF | 4282 | Anxiety Disorders | C0003469 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | group |
MIF | 4282 | Anaplastic carcinoma | C0205696 | Neoplastic Process | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Breast Carcinoma | C0678222 | Neoplastic Process | 0.35 | 0.457 | 0.862 | disease |
MIF | 4282 | Mammary Carcinoma, Animal | C1257925 | Neoplastic Process | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Rheumatoid Arthritis | C0003873 | Disease or Syndrome | 0.4 | 0.457 | 0.862 | disease |
MIF | 4282 | Undifferentiated carcinoma | C0205698 | Neoplastic Process | 0.3 | 0.457 | 0.862 | phenotype |
MIF | 4282 | Memory Disorder, Semantic | C0751293 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Memory Disorder, Spatial | C0751294 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | C3658302 | Disease or Syndrome | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Anxiety States, Neurotic | C0376280 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Age-Related Memory Disorders | C0751292 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Severe Sepsis | C1719672 | Disease or Syndrome | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Anxiety neurosis (finding) | C1279420 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Rheumatoid Arthritis, Systemic Juvenile | C1858558 | Disease or Syndrome | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Mycoplasma-Induced Stevens-Johnson Syndrome | C3658301 | Disease or Syndrome | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Depressive Syndrome | C0086133 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Malignant mesothelioma | C0345967 | Neoplastic Process | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Endogenous depression | C0011573 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Stevens-Johnson Syndrome | C0038325 | Disease or Syndrome | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Unipolar Depression | C0041696 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Carcinoma, Spindle-Cell | C0205697 | Neoplastic Process | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Memory impairment | C0233794 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | phenotype |
MIF | 4282 | Depression, Neurotic | C0282126 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Autistic Disorder | C0004352 | Mental or Behavioral Dysfunction | 0.31 | 0.457 | 0.862 | group |
MIF | 4282 | Mammary Neoplasms, Experimental | C0024668 | Experimental Model of Disease; Neoplastic Process | 0.3 | 0.457 | 0.862 | group |
MIF | 4282 | Memory Loss | C0751295 | Sign or Symptom | 0.3 | 0.457 | 0.862 | phenotype |
MIF | 4282 | Memory Disorders | C0025261 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Prostatic Neoplasms | C0033578 | Neoplastic Process | 0.34 | 0.457 | 0.862 | group |
MIF | 4282 | Sepsis | C0243026 | Disease or Syndrome | 0.33 | 0.457 | 0.862 | disease |
MIF | 4282 | Mammary Neoplasms, Human | C1257931 | Neoplastic Process | 0.3 | 0.457 | 0.862 | group |
MIF | 4282 | Drug-Induced Stevens Johnson Syndrome | C1274933 | Disease or Syndrome | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Malignant neoplasm of breast | C0006142 | Neoplastic Process | 0.34 | 0.457 | 0.862 | disease |
MIF | 4282 | Inflammation | C0021368 | Pathologic Function | 0.36 | 0.457 | 0.862 | phenotype |
MIF | 4282 | Mammary Neoplasms | C1458155 | Neoplastic Process | 0.32 | 0.457 | 0.862 | group |
MIF | 4282 | Depressive disorder | C0011581 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Toxic Epidermal Necrolysis | C0014518 | Disease or Syndrome | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Animal Mammary Neoplasms | C0024667 | Neoplastic Process | 0.3 | 0.457 | 0.862 | group |
MIF | 4282 | Malignant neoplasm of prostate | C0376358 | Neoplastic Process | 0.33 | 0.457 | 0.862 | disease |
MIF | 4282 | Septicemia | C0036690 | Disease or Syndrome | 0.31 | 0.457 | 0.862 | disease |
MIF | 4282 | Carcinomatosis | C0205699 | Neoplastic Process | 0.3 | 0.457 | 0.862 | phenotype |
MIF | 4282 | Carcinoma | C0007097 | Neoplastic Process | 0.3 | 0.457 | 0.862 | group |
MIF | 4282 | Melancholia | C0025193 | Mental or Behavioral Dysfunction | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Familial Ménière disease | C4302111 | Disease or Syndrome | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Juvenile-Onset Still Disease | C0087031 | Disease or Syndrome | 0.3 | 0.457 | 0.862 | disease |
MIF | 4282 | Systemic onset juvenile chronic arthritis | C1384600 | Disease or Syndrome | 0.32 | 0.457 | 0.862 | disease |
MIF | 4282 | Schizophrenia | C0036341 | Mental or Behavioral Dysfunction | 0.01 | 0.457 | 0.862 | disease |